The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Nivolumab + chemotherapy versus chemotherapy as neoadjuvant treatment for resectable stage IIIA NSCLC: Primary endpoint results of pathological complete response (pCR) from phase II NADIM II trial.
 
Mariano Provencio-Pulla
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; MSD; Roche; Takeda
Speakers' Bureau - AstraZeneca; BMS; MSD; Roche
Research Funding - Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Pierre Fabre (Inst); Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca; BMS; ROCHE
 
Ernest Nadal
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; MSD; Pfizer; Roche; Sanofi; Takeda
Research Funding - Bristol-Myers Squibb (Inst); Merck Serono (Inst); Pfizer (Inst); Roche (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Lilly; MSD; Pfizer; Roche
 
Jose Luis Gonzalez Larriba
No Relationships to Disclose
 
Alex Martinez-Marti
Consulting or Advisory Role - AstraZeneca/MedImmune; Boehringer Ingelheim; Bristol-Myers Squibb; Merck Sharp & Dohme; MSD Oncology; Pfizer; Roche
Speakers' Bureau - AstraZeneca/MedImmune; Boehringer Ingelheim; Bristol-Myers Squibb; Merck Sharp & Dohme; Pfizer; Roche
Travel, Accommodations, Expenses - AstraZeneca/MedImmune; Boehringer Ingelheim; Bristol-Myers Squibb; Merck Sharp & Dohme; Pfizer; Roche
 
Reyes Bernabé
No Relationships to Disclose
 
Joaquim Bosch-Barrera
No Relationships to Disclose
 
Joaquin Casal
No Relationships to Disclose
 
Virginia Calvo
Consulting or Advisory Role - AstraZeneca Spain; Boehringer Ingelheim; Bristol-Myers Squibb/Celgene; Lilly; MERK SHARP & DOHME; Pfizer; Roche/Genentech; Takeda
 
Amelia Insa
No Relationships to Disclose
 
Santiago Ponce Aix
No Relationships to Disclose
 
Noemi Reguart
Consulting or Advisory Role - Amgen; AstraZeneca; BMS; Boehringer Ingelheim; Janssen; Lilly; MSD Oncology; Pfizer; Roche; Sanofi; Takeda
Speakers' Bureau - Amgen; AstraZeneca; Boehringer Ingelheim; Merck Serono; MSD; Novartis; Roche; Roche Molecular Diagnostics; Sanofi; Takeda
Research Funding - Novartis; Pfizer
Travel, Accommodations, Expenses - MSD; Roche
 
Javier De Castro Carpeño
No Relationships to Disclose
 
Joaquín Mosquera
No Relationships to Disclose
 
Raquel Benitez
No Relationships to Disclose
 
Carlos Aguado De La Rosa
No Relationships to Disclose
 
Ramon Palmero
No Relationships to Disclose
 
Florentino Hernando-Trancho
No Relationships to Disclose
 
Atocha Romero
No Relationships to Disclose
 
Alberto Cruz Bermudez
No Relationships to Disclose
 
Bartomeu Massuti
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Janssen; Merck Serono; Roche; Takeda
Speakers' Bureau - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Roche
Travel, Accommodations, Expenses - Roche